ArticleThe Lancet. Oncology2018
Maintenance PARP inhibitor therapy: is maintaining quality of life enough?
Sara Bouberhan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2018
Sara Bouberhan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.